Method for Constructing Human iPS Cell Line RZPBi001 from Peripheral Blood Cells

Journal Title: Journal of Clinical & Cellular Immunology - Year 2023, Vol 14, Issue 3

Abstract

Patient-derived hiPSCs could generate indefinitely illness-related cells and organoids, allowing research scientist to reproduce some pathologic change of human sickness models in petri dishes. Whereas, dermal fibroblasts require some traumatic injury to obtain and have the risky of accumulating variations due to unveil to external stimulus such as UV light. Meanwhile, peripheral blood is regarded to be a more excellent source of somatopiasm because it is less damage to collect and its mutation load is significantly lower than that of skin tissue. In this paper, we describe the successful construction of non-integration hiPSCs form human peripheral blood cells by Sendai virus. A healthy adult female of Han nationality from China contributed her Peripheral Blood Mononuclear Cells (PBMCs). Non-integrating Sendai virus recombinant PBMCs with human OSKM (Oct4, Sox2, Kl4 and c-Myc) transcription factors. The pluripotency of transgenic-free iPSCs was confirmed by immunofluorescence staining of pluripotency markers and the capacity of iPSCs to initially differentiate into 3 germ layers in vitro. Moreover, iPSC lines demonstrated awfully normal karyotypes. In the research of illness progression and pathogenesis (eg, DMD, SMA, ALS), iPSC lines can be used as controls.

Authors and Affiliations

Xiaoqing Chen Yuling Lua Rong Ying Weiming Yua Pengfei Tian Dongming Hua Yu Feng

Keywords

Related Articles

Exercise-Mediated Immune Protection in Chronic Kidney Disease Decreases Infection and Severe Evolution of COVID-19

It is constantly sought to understand the different mechanisms of action of the immune system to establish potential efficient therapeutic targets for different clinical situations. Thus, the present study aims to expand...

Diagnostic Challenges and Immunological Barriers in Kidney Transplantation

The presence of donor specific antibodies and HLA-incompatibility between waiting list patients and potential donors make transplantation programs worldwide complicated and stand as a major barrier for a quick access for...

Indoleamine 2,3-Dioxygenase (IDO); Silenced Dendritic Cell Vaccine with Ipilimumab in Treating Metastatic Melanoma Patients: A Case Report

Immunotherapy has revolutionized the treatment landscape for metastatic melanoma. This case report presents the clinical course of a patient with metastatic melanoma who received combination therapy with ipilimumab, a CT...

Hotairm1 Controls S100A9 Protein Phosphorylation in Myeloid-Derived Suppressor Cells during Sepsis

During the acute phase of sepsis, the S100A9 proinflammatory protein resides in the cytosol in a phosphorylated form. In contrast, S100A9 relocalizes to the nucleus in an unphosphorylated form during the late/chronic sep...

Measurement of Post Challenging Immune Response (Serum?s Th1, Th2 Cytokines and Spleen?s CD Markers) with L.Major Amastigote in Balb/c Mice

Introduction: Leishmaniasis is a disease caused by the Leishmania major parasites and afflicted a large number of people every year. This disease is immunologically complex and in some cases, spontaneous improvement is a...

Download PDF file
  • EP ID EP741781
  • DOI 10.35248/2155-9899.23.14.686.
  • Views 11
  • Downloads 0

How To Cite

Xiaoqing Chen Yuling Lua Rong Ying Weiming Yua Pengfei Tian Dongming Hua Yu Feng (2023). Method for Constructing Human iPS Cell Line RZPBi001 from Peripheral Blood Cells. Journal of Clinical & Cellular Immunology, 14(3), -. https://europub.co.uk/articles/-A-741781